<< It would be even funnier if I didn't own so much<g>. >>
Same here!
But, if LGND performs, over the next 12 months, as I feel that it will, we'll be golfing in Hawaii. If not, we'll be caddying in Brooklyn. I'll be amazed if LGND doesn't hit at least $20, within the next 12 months, as long as their NDA programs go well.
Work has been keeping me very busy, unfair as that might seem. : > {
I just got thru looking at a 40 month chart of LGND. It sure looks like it is forming a springboard. The downward movement, over the last few months, has been in a fairly tight range, when compared historically. I like what I've seen. Of course, I would like it better if LGND was at $20 right now. <G>
I also feel that LGND's markets for the Panretin Gel (KS) and ONTAK, are a lot bigger than they look. I think that Ligand went after the AIDS KS market, because it was much easier to get enrollment for a skin cancer, for which there wasn't a satisfactory treatment. Once approved, the next step, to a more common form of skin cancer, could be relatively short in coming. No?! Yes?! Maybe?!
Anyway, I just thought that I would pop up here, and throw out a few positive comments.
Good luck, Bob |
